1-3 of 3
Authors: Yu-Hong Li
Save search
Sort by
Journal Article

158. PACLITAXEL PLUS CISPLATIN AND 5 FUOROURACIL INDUCTION CHEMOTHERAPY FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: 3-YEAR SURVIVAL RESULT Free

PDF
Jia-Di Wu and others
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.035, https://doi.org/10.1093/dote/doad052.035
Published: 30 August 2023
Journal Article

152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL Free

PDF
Jia-Di Wu and others
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.032, https://doi.org/10.1093/dote/doad052.032
Published: 30 August 2023
Journal Article

Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis Get access

PDF
Fei Zhang and others
Diseases of the Esophagus, Volume 30, Issue 2, February 2017, Pages 1–8, https://doi.org/10.1111/dote.12490
Published: 17 January 2017